HMGB1 and neoplasm: In the present study, we further demonstrated that SKN-induced ICD in CT26 cells in a dose-dependent manner by measuring levels of ROS, ATP, HMGB1, and CRT, providing a strong evidence for using SKN in producing the in situ tumor vaccines.